Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b Double-Blind Study of S-2367 in Obese Patients With Metabolic Comorbidities
jRCT2080221761Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of velneperit in obesity, type 2 diabetes mellitus (T2DM), dysglycemia and 2 more, sponsored by Shionogi & Co., Ltd.
02
Drugs
velneperit
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)dysglycemiadyslipidemiaAbdominal adiposity (ABCD)
Beyond the preview
Go deeper on jRCT2080221761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221761.